


Ask a doctor about a prescription for OLANZAPINE QUALIGEN 5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Olanzapine Qualigen 5mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
OLANZAPINE QUALIGEN belongs to a group of medicines called antipsychotics and is used to treat the following diseases:
OLANZAPINE QUALIGEN has been shown to prevent the recurrence of these symptoms in patients with bipolar disorder whose manic episodes have responded to treatment with olanzapine.
Do not take OLANZAPINE QUALIGEN
Warnings and precautions
Consult your doctor or pharmacist before starting to take OLANZAPINE QUALIGEN
If you suffer from any of the following diseases, tell your doctor as soon as possible:
If you suffer from dementia, you or your caregiver or family member should inform your doctor if you have ever had a stroke or a lack of blood flow to the brain.
As a routine precaution, if you are over 65 years old, it would be advisable for your doctor to check your blood pressure.
Children and adolescents
Patient under 18 years should not take OLANZAPINE QUALIGEN
Use of OLANZAPINE QUALIGEN with other medicines
Only use other medicines at the same time as OLANZAPINE QUALIGEN if your doctor authorizes it. You may feel a certain sensation of sleepiness if you combine OLANZAPINE QUALIGEN with antidepressants or medicines for anxiety or that help you sleep (tranquilizers).
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.
In particular, tell your doctor if you are taking:
Use of OLANZAPINE QUALIGEN with alcohol
You should not drink alcohol if you have been given OLANZAPINE QUALIGEN because it can cause sleepiness.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. You should not take this medicine when you are breastfeeding, as small amounts of OLANZAPINE QUALIGEN may pass into breast milk.
The following symptoms may occur in newborns of mothers who have used OLANZAPINE QUALIGEN in the last trimester (last three months of pregnancy): tremors, muscle stiffness and/or weakness, sleepiness, agitation, respiratory problems, and difficulty feeding. If your baby has any of these symptoms, contact your doctor.
Driving and using machines
There is a risk of sleepiness when taking OLANZAPINE QUALIGEN. If this happens to you, do not drive vehicles or use machinery. Consult your doctor.
OLANZAPINE QUALIGEN contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many OLANZAPINE QUALIGEN tablets you should take and for how long. The daily dose of OLANZAPINE QUALIGEN ranges from 5 to 20 mg. Consult your doctor if you suffer from symptoms again, but do not stop taking OLANZAPINE QUALIGEN unless your doctor tells you to.
You should take your OLANZAPINE QUALIGEN tablets once a day, following your doctor's instructions. Try to take the tablets at the same time every day. You can take them with or without food. OLANZAPINE QUALIGEN film-coated tablets are for oral administration. You should swallow the OLANZAPINE QUALIGEN tablets whole with water.
If you take more OLANZAPINE QUALIGEN than you should
Patient who have taken more OLANZAPINE QUALIGEN than they should have experienced the following symptoms: rapid heartbeat, agitation/aggression, speech problems, unusual movements (especially of the face and tongue), and a reduced level of consciousness. Other symptoms may be: acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating, muscle stiffness, and a state of confusion or drowsiness, slowing of respiratory rate, aspiration, increased blood pressure or decreased blood pressure, abnormal heart rhythms.
Contact your doctor or go to the hospital immediately if you notice any of the above symptoms. Show the doctor the package with the tablets.
If you forget to take OLANZAPINE QUALIGEN
Take your tablets as soon as you remember. Do not take a double dose to make up for forgotten doses.
If you stop taking OLANZAPINE QUALIGEN
Do not stop treatment just because you feel better. It is very important that you continue taking OLANZAPINE QUALIGEN while your doctor tells you to.
If you stop taking OLANZAPINE QUALIGEN suddenly, symptoms such as sweating, insomnia, tremors, anxiety, or nausea and vomiting may appear. Your doctor may suggest that you gradually reduce the dose before stopping treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you have:
Very common side effects (may affect more than 1 in 10 people) include weight gain, sleepiness, and increased prolactin levels in the blood.
Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells and circulating lipids, increased blood sugar and urine levels, increased appetite, dizziness, agitation, tremors, muscle stiffness or spasms (including eye movements), language disorders, constipation, dry mouth, skin rash, loss of strength, excessive fatigue, fluid retention that causes swelling of the hands, ankles, or feet, and sexual dysfunction such as decreased libido in men and women or erectile dysfunction in men. In the early stages of treatment, some people experience dizziness or fainting (with slower heartbeats), especially when getting up from lying down or sitting. This sensation usually disappears on its own, but if it does not, tell your doctor.
Rare side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g., inflammation of the mouth and throat, itching, skin rash); diabetes or worsening of diabetes, occasionally related to ketoacidosis (acetone in blood and urine) or coma; seizures, in most cases related to a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; speech problems; slow pulse; sensitivity to sunlight; nosebleeds; abdominal distension; memory loss or forgetfulness; urinary incontinence; loss of urination ability; hair loss; absence or decrease of menstrual periods; and changes in the mammary gland in men and women, such as abnormal milk production or growth.
Other side effects whose frequency cannot be estimated from the available data (unknown) include a drop in body temperature, abnormal heart rhythm, sudden unexplained death, pancreatitis, which causes severe stomach pain, fever, and discomfort, liver disease, with yellowing of the skin and the white parts of the eyes, muscle disorder that presents as unexplained pain and prolonged and/or painful erections.
During treatment with olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme fatigue, visual hallucinations, a rise in body temperature, redness of the skin, and walking problems. Some deaths have been reported in this particular group of patients.
OLANZAPINE QUALIGEN may worsen symptoms in patients with Parkinson's disease
Severe allergic reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been reported. DRESS appears initially with symptoms similar to those of the flu, with a rash on the face that then spreads to other areas, fever, swelling of the lymph nodes, elevated liver enzyme levels in blood tests, and an increase in a type of white blood cell (eosinophilia).
If you experience side effects, consult your doctor or pharmacist, even if it is a side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, http://www.notificaRAM.es/.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Olanzapine Qualigen after the expiry date stated on the package after EXP. The expiry date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Place the packages and medicines you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of OLANZAPINE QUALIGEN
Appearance of the product and contents of the pack
Olanzapine Qualigen 5 mg is presented in the form of film-coated tablets. The tablets are round, white, and have the inscription “5” on one side.
They are presented in packages of 28 tablets.
Other presentations:
Olanzapine Qualigen 2.5 mg film-coated tablets EFG
Olanzapine Qualigen 7.5 mg film-coated tablets EFG
Olanzapine Qualigen 10 mg film-coated tablets EFG
Marketing authorization holder and manufacturer
Marketing authorization holder:
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona Spain
Manufacturer:
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona Spain
Date of last revision of this leaflet:July 2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of OLANZAPINE QUALIGEN 5 mg FILM-COATED TABLETS in October, 2025 is around 26.44 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OLANZAPINE QUALIGEN 5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.